Reuters logo
in 2 months
BRIEF-Ligand Pharmaceuticals enters into agreements with Interventional Analgesix
May 23, 2017 / 8:51 PM / in 2 months

BRIEF-Ligand Pharmaceuticals enters into agreements with Interventional Analgesix

1 Min Read

May 23 (Reuters) - Ligand Pharmaceuticals Inc

* On May 22, 2017, entered into a license agreement and a supply agreement with privately-held interventional analgesix, inc

* Agreement grants IAX exclusive right to use Captisol in development and commercialization of Captisol-enabled version of specified compound

* Will receive an upfront payment, and could also potentially receive milestone payments, plus tiered royalties of 5 pct -10 pct of net sales

* Says could receive commercial revenue from shipment of Captisol to IAX for clinical and commercial activities Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below